MedTrace Logo

Feasibility Study for Instant Cardiac Diagnostic and Post-operative Risk Assessment with the LynxPatch Device

NCT05987904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1097

Last updated 2024-10-30

No results posted yet for this study

Summary

In this clinical study the investigators will evaluate if it is feasible to pre-operatively identify low-risk patients, and to identify patients with cardiac pathologies with the LynxPatch.

Conditions

Interventions

DEVICE

LynxPatch

Measurements with the LynxPatch device are conducted.

Sponsors & Collaborators

  • Meditrial Europe Ltd.

    collaborator INDUSTRY

  • Lynx Health Science GmbH

    lead INDUSTRY

Principal Investigators

  • Aydan Ewers, Dr. med. · BG Universitätsklinikum Bergmannsheil

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-02
Primary Completion
2024-06-20
Completion
2024-06-20

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05987904 on ClinicalTrials.gov